BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9423814)

  • 21. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model.
    Yu KM; Inoue Y; Umeda M; Terasaki H; Chen ZY; Iwai T
    Thromb Res; 2011 May; 127(5):418-25. PubMed ID: 21334044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
    Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
    Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of activated platelets and platelet-leukocyte aggregates in horses.
    Weiss DJ; Evanson OA
    Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
    Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
    Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
    Nkambule BB; Davison G; Ipp H
    Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
    Yang X; Disa J; Rao AK
    Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
    Ito H; Miyakoda G; Mori T
    Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates.
    Klinkhardt U; Kuczka K; Harder S
    Thromb Res; 2003; 111(4-5):251-7. PubMed ID: 14693172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro.
    Calmer S; Ferkau A; Larmann J; Johanning K; Czaja E; Hagl C; Echtermeyer F; Goudeva L; Heuft HG; Theilmeier G
    Platelets; 2014; 25(1):8-15. PubMed ID: 23534885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C1q induces a rapid up-regulation of P-selectin and modulates collagen- and collagen-related peptide-triggered activation in human platelets.
    Skoglund C; Wetterö J; Tengvall P; Bengtsson T
    Immunobiology; 2010 Dec; 215(12):987-95. PubMed ID: 20163886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometry analysis of porcine platelets: optimized methods for best results.
    Krajewski S; Kurz J; Wendel HP; Straub A
    Platelets; 2012; 23(5):386-94. PubMed ID: 22035358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of halothane and isoflurane on binding of ADP- and TRAP-6- activated platelets to leukocytes in Whole blood.
    de Rossi LW; Horn NA; Hecker KE; Robitzsch T; Hutschenreuter G; Rossaint R
    Anesthesiology; 2002 Jan; 96(1):117-24. PubMed ID: 11753011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases].
    Wang J; Cao L; He M
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric detection of activated platelets in the dog.
    Moritz A; Walcheck BK; Weiss DJ
    Vet Clin Pathol; 2003; 32(1):6-12. PubMed ID: 12655482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of aflibercept on platelet activation profile.
    Sobolewska B; Golenko J; Poeschel S; Grimmel C; Gatsiou A; Sopova K; Biedermann T; Schenke-Layland K; Stellos K; Ziemssen F
    Exp Eye Res; 2018 Oct; 175():166-172. PubMed ID: 29908884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression.
    Klinkhardt U; Wenzel E; Harder S
    Platelets; 2006 Feb; 17(1):42-8. PubMed ID: 16308186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system.
    Macey MG; Carty E; Webb L; Chapman ES; Zelmanovic D; Okrongly D; Rampton DS; Newland AC
    Cytometry; 1999 Oct; 38(5):250-5. PubMed ID: 10516612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
    Ruef J; Kuehnl P; Meinertz T; Merten M
    Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inhibiting effect of adenosine on platelet activation in vitro].
    Wang DM; Liu JH; Zhou J; Ouyang XL; Xing YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1094-8. PubMed ID: 16403288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.